{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:07:37Z","timestamp":1791828457966,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ejmech.2016.01.030","type":"journal-article","created":{"date-parts":[[2016,1,20]],"date-time":"2016-01-20T01:45:37Z","timestamp":1453254337000},"page":"259-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"special_numbering":"C","title":["Amido\/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar\/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII"],"prefix":"10.1016","volume":"110","author":[{"given":"Wagdy M.","family":"Eldehna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Fares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Ceruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazem A.","family":"Ghabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar M.","family":"Abou-Seri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem A.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalal A.","family":"Abou El Ella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2016.01.030_bib1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2012","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2016.01.030_bib3","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1016\/j.bmc.2013.06.029","article-title":"Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides","volume":"21","author":"Akdemir","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib4","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1016\/j.bmc.2015.05.013","article-title":"New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: biological evaluation and molecular modelling studies","volume":"23","author":"Carradori","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib5","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1016\/j.bmc.2015.07.066","article-title":"Exploring new Probenecid-based carbonic anhydrase inhibitors: synthesis, biological evaluation and docking studies","volume":"23","author":"Mollica","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0223-5234(98)80033-0","article-title":"Carbonic anhydrase inhibitors. Part 49. Synthesis of substituted ureido and thioureido derivatives of aromatic\/heterocyclic sulfonamides with increased affinities for isozyme I","volume":"33","author":"Supuran","year":"1998","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/14756369809035830","article-title":"Carbonic anhydrase inhibitor: ureido and thioureido derivatives of aromatic sulfonamides possessing increased affinities for isozymes I. A novel route to 2, 5-disubstituted-1,3,4-thidiazoles via thioureas and their interaction with isozymes I, II and IV","volume":"13","author":"Scozzafava","year":"1998","journal-title":"J.\u00a0Enzyme Inhib."},{"key":"10.1016\/j.ejmech.2016.01.030_bib8","first-page":"343","article-title":"Carbonic anhydrase inhibitors. arylsulfonylureido- and arylureido-substituted aromatic and heterocyclic sulfonamides: towards selective inhibitors of carbonic anhydrase isozyme I","volume":"14","author":"Supuran","year":"1999","journal-title":"J.\u00a0Enzyme Inhib."},{"key":"10.1016\/j.ejmech.2016.01.030_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bmcl.2010.11.064","article-title":"Inhibition of \u03b2-carbonic anhydrases with ureido-substituted benzenesulfonamides","volume":"21","author":"Pacchiano","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.01.030_bib10","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1016\/j.bmcl.2012.05.083","article-title":"Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines","volume":"22","author":"Winum","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.01.030_bib11","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1016\/j.bmc.2014.10.041","article-title":"Inhibition studies of new ureido-substituted sulfonamides incorporating a GABA moiety against human carbonic anhydrase isoforms I\u2013XIV","volume":"22","author":"Ceruso","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib12","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1016\/j.bmc.2015.07.024","article-title":"Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties","volume":"23","author":"Congiu","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib13","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1016\/j.bmcl.2015.07.060","article-title":"Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity","volume":"25","author":"Congiu","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.01.030_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/14756366.2015.1014477","article-title":"Synthesis and inhibition potency of novel ureido benzenesulfonamides incorporating GABA as tumor-associated carbonic anhydrase IX and XII inhibitors","volume":"31","author":"Ceruso","year":"2016","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib15","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3109\/14756366.2014.986118","article-title":"Inhibition of carbonic anhydrase isoforms I, II, IX and XII with Schiff's bases incorporating iminoureido moieties","volume":"30","author":"Singasane","year":"2015","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2016.01.030_bib17","doi-asserted-by":"crossref","first-page":"8371","DOI":"10.1039\/c0cc02707c","article-title":"Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency","volume":"46","author":"Pacchiano","year":"2010","journal-title":"Chem. Commun. Camb. U. K.)"},{"key":"10.1016\/j.ejmech.2016.01.030_bib18","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib19","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2016.01.030_bib20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/13543776.2013.798648","article-title":"Anticancer carbonic anhydrase inhibitors: a patent review (2008 \u2013 2013)","volume":"23","author":"Monti","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2016.01.030_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18632\/oncotarget.422","article-title":"Recent developments in targeting carbonic anhydrase IX for cancer therapeutics","volume":"3","author":"McDonald","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2016.01.030_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/14756366.2013.761876","article-title":"Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnological use for CO2 capture","volume":"28","author":"Supuran","year":"2013","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib23","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1038\/onc.2012.550","article-title":"Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche","volume":"32","author":"Lock","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2016.01.030_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejmech.2014.05.039","article-title":"Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII","volume":"82","author":"S\u0142awi\u0144ski","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib25","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4172\/2161-0444.1000179","article-title":"Isatins: a diversity orientated biological profile","volume":"4","author":"Kidwai","year":"2014","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib26","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.1039\/C5OB00688K","article-title":"Discovery of novel isatin-based sulfonamides with potent and selective inhibition of the tumor associated carbonic anhydrase isoforms IX and XII","volume":"13","author":"G\u00fczel-Akdemir","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib27","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1016\/j.bmc.2007.07.044","article-title":"Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity","volume":"15","author":"Abdel-Hamid","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1947601909356574","article-title":"Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates","volume":"1","author":"Loges","year":"2010","journal-title":"Genes cancer"},{"key":"10.1016\/j.ejmech.2016.01.030_bib29","first-page":"14","article-title":"Angiogenesis in cancer: anti-VEGF escape mechanisms","volume":"1","author":"Prager","year":"2012","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.ejmech.2016.01.030_bib30","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1200\/JCO.2012.41.9242","article-title":"Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies","volume":"30","author":"Bottsford-Miller","year":"2012","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ejmech.2016.01.030_bib31","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/bjc.2013.429","article-title":"Changes in tumour vessel density upon treatment with anti-angiogenic agents: relationship with response and resistance to therapy","volume":"109","author":"Vasudev","year":"2013","journal-title":"Br. J. cancer"},{"key":"10.1016\/j.ejmech.2016.01.030_bib32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/1471-2407-9-246","article-title":"Carbonic anhydrase 9 is a predictive marker of survival benefit from lower dose of bevacizumab in patients with previously treated metastatic colorectal cancer","volume":"9","author":"Hong","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejmech.2016.01.030_bib33","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1158\/1078-0432.CCR-11-1877","article-title":"Carbonic anhydrase IX promotes tumour growth and necrosis in\u00a0vivo and inhibition enhances anti-VEGF therapy","volume":"18","author":"McIntyre","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2016.01.030_bib34","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nrclinonc.2012.64","article-title":"Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia","volume":"9","author":"Rapisarda","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2016.01.030_bib35","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1016\/j.bmcl.2013.03.099","article-title":"Synthesis and antiproliferative evaluation of piperazine-1-carbothiohydrazide derivatives of indolin-2-one","volume":"11","author":"Lin","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.01.030_bib36","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1021\/jm060001n","article-title":"3-Arylimino-2-indolones are potent and selective galanin GAL3 receptor antagonists","volume":"49","author":"Konkel","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/jhet.5570350221","article-title":"New isomeric N-substituted hydrazones of 2-, 3-and 4- pyridinecarboxaldehydes","volume":"35","author":"Wyrzykiewicz","year":"1998","journal-title":"J.\u00a0Het. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib38","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ejmech.2004.06.007","article-title":"Synthesis and antimicrobial activities of some new 1-(5-phenylamino-[1,3,4]thiadiazol-2-yl)methyl-5-oxo-[1,2,4]triazolo and 1-(4-phenyl-5-thioxo-[1,2,4]triazol-3-yl)methyl-5-oxo- [1,2,4]triazole derivatives","volume":"39","author":"Demirbas","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib39","first-page":"7","article-title":"Synthesis, crystal structure and biological activity of cis\/trans amide rotomers of (Z)-N'-(2-oxoindolin-3-ylidene)formohydrazide","author":"Abdel-Aziz","year":"2014","journal-title":"J.\u00a0Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib40","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1021\/ja01228a060","article-title":"Derivatives of Sulfanilamide. I. N4-(p-Aminobenzoyl)-sulfanilamide and Related Compounds","volume":"67","author":"Chu","year":"1945","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2016.01.030_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejmech.2015.05.040","article-title":"Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in\u00a0vitro biological evaluation and molecular docking","volume":"100","author":"Eldehna","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib42","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib43","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3109\/14756366.2011.650168","article-title":"Inhibition of the \u03b2-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids","volume":"28","author":"Maresca","year":"2013","journal-title":"J.\u00a0Enz. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib44","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/14756366.2011.645539","article-title":"Dihalogenated sulfanilamides and benzolamides are effective inhibitors of the three \u03b2-class carbonic anhydrases from Mycobacterium tuberculosis","volume":"28","author":"Maresca","year":"2013","journal-title":"J.\u00a0Enz. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.01.030_bib45","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0960-894X(00)00722-8","article-title":"Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating dtpa tails and of their zinc complexes with powerful topical antiglaucoma properties","volume":"11","author":"Scozzafava","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.01.030_bib46","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.bmcl.2009.01.079","article-title":"Carbonic anhydrase inhibitors: Two-prong versus mono-prong inhibitors of isoforms I, II, IX, and XII exemplified by photochromic cis-1, 2-\u03b1-dithienylethene derivatives","volume":"19","author":"Vomasta","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416300319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416300319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:08:18Z","timestamp":1654128498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523416300319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":46,"alternative-id":["S0223523416300319"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.01.030","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amido\/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar\/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}